Bristol Myers Squibb reported a Phase 3 success and a pipeline cut as part of its second-quarter earnings Friday morning.
READ MOREVerona Pharma has secured up to $650 million to aid the potential launch of its COPD candidate ensifentrine.
READ MOREThe FDA has expanded the approval of BioMarin’s treatment for a genetic neurological condition that spurs seizures and twitching in young children.
READ MOREWelcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
READ MORE